23
Participants
Start Date
June 1, 2021
Primary Completion Date
August 28, 2023
Study Completion Date
August 28, 2023
Transcu O2®
Breasts randomized into study active group will be provided with a Transcu O2® at their surgical site and followed for 4 weeks.
Tegaderm
A 10 cm × 12 cm Tegaderm TM Film adhesive (3M Healthcare, Minnesota).
Silagen
A 10 cm × 12 cm silicon sheet (Silagen, New Medical Technology, Inc, Illinois).
Baylor College of Medicine, Houston
Electrochemical Oxygen Concepts, Inc.
INDUSTRY
Baylor College of Medicine
OTHER